MIRA INFORM REPORT

 

 

 

Report Date :

13.06.2008

 

IDENTIFICATION DETAILS

 

Name :

ATLANTA VINYLS PRIVATE LIMITED

 

 

Registered Office :

Plot No. 124 to133, Panchal Udyog Nagar, Bhimpore Daman - 396210

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

10.02.2004

 

 

Com. Reg. No.:

56-3385

 

 

CIN No.:

[Company Identification No.]

U27203DD2004PLC003385

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUME05284G

 

 

PAN No.:

[Permanent Account No.]

AABCE3113G

 

 

Legal Form :

Private Limited Liability Company.

 

 

Line of Business :

Manufacturers of Blister Alu Foil, Alu Foil for Strip Pack, Rigid PVC, Glassine Paper Foil.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

 

Maximum Credit Limit :

USD 10200000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having satisfactory track. The company is doing well. It’s trade relations are fair. Financial position is satisfactory. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office /

Factory :

Plot No. 124 to133, Panchal Udyog Nagar, Bhimpore Daman – 396210, India

Tel. No.:

91-260-2220314 / 15 / 3298250 / 3293224

Fax No.:

91-260-2220316

E-Mail :

flexart@duttagroup.net  / essdee@duttagroup.net /

darshan.majumdar@duttagroup.net

mayya@duttagroup.net

 

 

Corporate Office :

4TH Floor, Vidyasagar, Western Express Highway, Malad (East), Mumbai – 400097, Maharashtra

Tel. No.:

91-22-66919955

Fax No.:

91-22-66940985

E-Mail :

flexart@duttagroup.net, investorservice@duttagroup.net

Website :

http://www.duttagroup.in

 

 

Unit :

Atlanta Vinyls

Plot No. 161, Kundaim Industrial Estate, Kundaim, Goa 403 115.

Tel. No.:

91-832-2395422

Fax No.:

91-832-2395874

E-Mail :

flaxart@vsnl.com

Website :

http://www.duttagroup.net

 

 

DIRECTORS

 

Name :

Mr. Sudip Bijoy Dutta

Designation :

Chairman and Managing Director

Address :

Flat No. 506, Challenger Tower – 2, Thakur Village, Kandivali (East), Mumbai – 400101, Maharashtra

Date of Birth/Age :

04.05.1972

Date of Appointment :

10.02.2004

 

 

Name :

Mr. Prasenjit Datta

Designation :

Director

Address :

Flat No. 1704, Challenger Tower – 2, Thakur Village, Kandivali (East), Mumbai – 400101, Maharashtra

Date of Birth/Age :

16.06.1963

Date of Appointment :

30.04.2004

 

 

Name :

Mr. Shankar Sadashiv Kamble

Designation :

Director

Address :

No. 305, Sai Sharan, N. C. Kelkar Road, Dadar (West), Mumbai – 400028

Date of Birth/Age :

21.02.1946

Date of Appointment :

31.03.2006

 

 

Name :

Mr. Gautan Mukherjee

Designation :

Director

 

 

Name :

Mr. Ramdas L Baxi

Designation :

Director

 

 

Name :

Mr. Dilip Phatarphekar

Designation :

Director

 

 

Name :

Mrs. Aarti Sudip Dutta

Designation :

Director

Address :

Flat No. 506, Challenger Tower – 2, Thakur Village, Kandivali (East), Mumbai – 400101, Maharashtra

Date of Birth/Age :

01.09.1980

Date of Casing :

31.03.2006

Date of Appointment :

27.06.2005

 

 

Name :

Mr. Narayana Mayya

Designation :

Director

Address :

Raas B – 301 Vasantutsav, Thakur Village, Kandivali (East), Mumbai – 400101, Maharashtra

Date of Birth/Age :

29.11.1953

Date of Casing :

31.03.2006

Date of Appointment :

15.09.2005

 

 

KEY EXECUTIVES

 

Name :

Mr. Darshan Drupad Majmudar

Designation :

Company Secretary

Address :

Flat No. A 3, Sahyagiri C. F. S. Limited (East), Mumbai – 400063, Maharashtra, India

Date of Birth/Age :

07.06.1961

Date of Appointment :

12.04.2006

 

 

 

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

 

No. of Shares

Mr. Sudip Bijoy Dutta

 

7274500

Mrs. Aarti Sudip Dutta

 

234500

Mr. Prasenjit Datta

 

200

Vinaya Nilesh Desai

 

200

Ajoy Premkumar Malhotra

 

200

Manash Tarun Mazumdar

 

200

Ajay Sushil Doshi

 

200

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers of Blister Alu Foil, Alu Foil for Strip Pack, Rigid PVC, Glassine Paper Foil.

 

 

Products :

Production Description

ITC Code No.

Manufacturer of Bristle Aluminium / PVC Rigid Film

76.07 / 39.20

 

 

GENERAL INFORMATION

 

Customer :

·         CIPLA

·         Pfizer

·         Wockhardt

·         DRL

·         TorrenT

·         IPCA

·         Lupin

·         Wyeth

·         Sun Pharma

·         Intas

·         Cadila Pharma

·         Aurobindo

·         Unichem

·         Blue Cross

·         Glenmark

·         Serdia

·         Bayer

·         Wriggleys

·         J B Chemicals

·         Ranbaxy

·         Madras Pharma

·         Ind Chemie

·         Indoco

·         Hetero

·         GSK

·         Dr. Reddys Lab

·         Themis Labs

·         Zydus Cadila

·         Reckitt Benckiser

·         CFL

 

 

No. of Employees :

900

 

 

Bankers :

v      The Shamrao Vithal Co-Operative Bank Limited,

     Goregaon

     Mumbai

     Maharashtra

     Credit Limit: Rs. 50.000 millions

 

 

 

 

Auditors :

M. P. Chitale and Company

Chartered Accountants 

Daman

 

 

Associates/Subsidiaries :

Flex Art Foil Private Limited

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

35000000

Equity Shares

Rs. 10/- each

Rs. 350.000 Millions

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

26414800

Equity Shares

Rs. 10/- each

Rs. 264.148 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

264.100

75.100

15.100

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1792.800

98.735

0.772

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

2056.900

173.835

15.872

LOAN FUNDS

 

 

 

1] Secured Loans

258.500

237.446

82.131

2] Unsecured Loans

0.900

19.916

21.224

TOTAL BORROWING

259.400

257.362

103.355

DEFERRED TAX LIABILITIES

0.000

13.978

0.000

 

 

 

 

TOTAL

2316.300

445.175

119.227

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

266.500

153.634

79.879

Capital work-in-progress

341.200

34.585

0.000

 

 

 

 

INVESTMENT

555.900

40.156

0.049

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

165.200

80.160

36.986

 

Sundry Debtors

637.200

222.669

29.953

 

Cash & Bank Balances

541.400

20.617

4.094

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

134.200

32.190

3.995

Total Current Assets

1478.000

355.636

75.028

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

232.100

127.906

34.223

 

Provisions

93.200

10.930

1.506

Total Current Liabilities

325.300

138.836

35.729

Net Current Assets

1152.700

21.680

39.299

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

2316.300

445.175

119.227

 

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2007

31.03.2006

31.03.2005

Sales Turnover

1529.500

716.700

95.300

Other Income

31.000

10.700

0.000

Total Income

1560.500

727.400

95.300

 

 

 

 

Profit/(Loss) Before Tax

312.900

118.200

0.900

Provision for Taxation

36.700

24.300

4.000

Profit/(Loss) After Tax

276.200

93.900

[3.100]

 

 

 

 

Expenditures :

 

 

 

 

Raw Materials

935.900

378.700

48.000

 

Excise Duty

122.300

92.000

13.300

 

Power & Fuel Cost

25.500

20.700

0.000

 

Other Manufacturing Expenses

46.500

39.700

21.300

 

Employee Cost

27.400

18.600

3.600

 

Selling and Administration Expenses

62.500

32.400

1.700

 

Miscellaneous Expenses

0.100

0.200

0.000

 

Preparative Expenditure Capitalised

[17.400]

[7.500]

0.000

 

Interest & Financial Charges

41.600

36.200

5.300

 

Depreciation

9.800

6.500

1..200

 

Stock Adjustments

[6.600]

[8.300]

[0.000]

Total Expenditure

1247.600

609.200

94.400

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

30.06.2007

30.09.2007

31.12.2007

31.03.2008

Type

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

Sales Turnover

648.300

635.300

618.900

90.2300

Other Income

14.200

33.600

14.900

1.6500

Total Income

662.500

668.900

633.800

91.8800

Total Expenditure

497.800

502.200

447.900

64.1500

Operating Profit

164.700

166.700

185.900

27.7300

Interest

13.100

10.500

8.000

1.3300

Gross Profit

151.600

156.200

177.900

26.4000

Depreciation

4.500

07.900

8.800

0.9300

Tax

15.900

34.200

17.200

3.4800

Reported PAT

131.200

114.100

151.900

21.9900

 


 

KEY RATIOS

 

PARTICULARS

 

31.03.2007

31.03.2006

31.03.2005

Debt-Equity Ratio

0.23

1.94

8.61

Long Term Debt-Equity Ratio

0.06

1.27

8.61

Current Ratio

2.14

1.36

1.89

Fixed Assets

6.72

5.79

1.01

Inventory

12.47

12.23

2.21

Debtors

3.56

5.67

2.72

Interest Cover Ratio

8.52

4.27

1.17

Operating Profit Margin(%)

23.82

22.45

7.76

Profit Before Interest And Tax Margin(%)

23.18

21.54

6.51

Cash Profit Margin(%)

18.70

14.01

-1.99

Adjusted Net Profit Margin(%)

18.06

13.10

-3.25

Return On Capital Employed(%)

25.81

56.51

0.00

Return On Net Worth(%)

24.76

101.08

0.00

 

 

LOCAL AGENCY FURTHER INFORMATION

 

PERFORMANCE REVIEW: 

 

The Company has recorded a significant growth in its performance. Total Income grew to Rs.1438.189 Millions, registering a growth of 126% over previous year Income of Rs.635.387 Millions. Profit after Tax Improved by 194% to Rs.276.178 Millions in the current year compared to Rs.93.908 Millions in the previous year.

The above growth has been possible primarily due to installation of additional capacity, efficient capacity utilization, besides Increase In their customers' base coupled with rapid growth in the pharmaceutical sector. 

 

INDUSTRY STRUCTURE AND DEVELOPMENT, OUTLOOK: 

Packaging combines technology and creativity In order to protect products and meet the criteria of safety, convenience and aesthetics. Its importance Is highlighted by the fact that it preserves the quality and lengthens the shelf life of the products. With the changing business environment in which they operate, packaging has acquired a new dimension of adding brand value to products. With increasing education levels, greater consumer awareness and rising disposable incomes with the new generation of health conscious consumers, there Is a discernible trend towards well packed and branded products. Besides, there Is also Increasing demand for low priced goods in smaller pack sizes resulting in customization. The Company's major business flows from the pharmaceutical segment and It constitutes a fast growing segment in India. Pharmaceutical packaging consists of various types of glass, pet bottles, strip and blister packs, injectibles, ampoules, bulk packs, etc. In today's times, the packaging function has extended from merely preservation of the medicines to prevention of product tampering and counterfeiting, the assurance of product dispensing accuracy and the promotion of patient compliance with product dosage schedules. 

Consumerism is set to Increase with advent of retail chains opening across the Country. The Company foresees explosive growth for quality packaging materials for years to come. To tap this accelerated demand, the Company is foraying Into Food & FMCG segment on the backing of satisfied global pharmaceutical companies in the Country. 

SEGMENT REVIEW: 

 
Aluminium Foil: 

During the year, aluminium rolling mill capacity was enhanced from 3600 tpa to 9100 tpa, following commissioning of the second cold rolling mill In the month of November, 2006. With the commencement of second cold roiling mill, the Company has now the facility of downguaging of foil to ultra thin gauges to meet demand for aluminium foils of the FMCG Industries.

 

They are passing through an economic growth phase and resultantly witnessing the opening up of retail chains across the Country and consequent demand for increased packaging requirements. Aluminium foil remains best suited for products requiring longer shelf life and preservation of properties. 

Realisation price per Kg has increased due to Introduction of thinner gauge of Aluminium foil. Company's plans for introduction of newer products are under customers' review and shortly these products are expected to be introduced commercially in the market. 

PVC/PVdC: 
 
During the year, the Company has set up and commissioned PVdC coating line for barrier sensitive high end pharmaceutical products. This has resulted in growth In revenue as well as better realization of margins, as there are very few manufacturers In the Country having similar facility.

During the year, the Company has also introduced metailzed PVC film and the same has been accepted favorably by the Industry.

Spurious drugs pose a serious threat to many pharma products and It has been the Company's endeavor to assist pharmaceutical companies with Innovative packaging solutions to thwart such menace. 
 

OPPORTUNITY AND THREATS: 

With the extension of value added products like cold formed 'Alu Alu' laminates and child resistant laminates, the Company is becoming a single point window solution provider to the pharmaceutical Industry. 

With the DMF (Drug Master File) type III accreditation and international acquisitions by Indian pharmaceutical companies, opportunities are opening up on the possibility of creating a Global Hub and Spoke model for serving international pharmaceutical companies out of India. Similarly, MNCs are now creating hubs and utilizing new found Interest in India as a sourcing centre. Pharmaceutical sector in India is booming as apparent from the fact that the maximum number of US ANDA's are from India and they also have the maximum number of USFDA approved pharmaceutical plants are from India.

With the opening of retail chains by large Indian business houses and presence of international players. In the retail sectors in India, there will be a proliferation of Food and FMCG requirement, which Is the new product foray the Company is going for.

Some of the major threats which they may face are on account of volatility in aluminium prices, fluctuation In foreign exchange rates, change In government policies and competition from existing and prospecting manufacturers' of Company's products. 

 

NEW PROJECT/NEW BUSINESS: 

The Company plans to foray Into manufacturing and supply of packaging materials for Food & FMCG segments. Setting up of facility for manufacturing of such materials is underway and most of the plant & machinery have also been received and commissioned. Sampling to business houses have been done and commercial operations are underway.

SUBSIDIARY: 
The Company has a wholly owned subsidiary, named M/s. Flex Art Foil Private Limited. It provides printing facilities to pharmaceutical companies for their packaging materials at various locations across the Country. With the Introduction of new products and spurt in the number of registered DMFs (Drug Master File), service vis a vis lead times have assumed primary Importance. With its unique 'Hub and Spoke' model. It is catering to the pharmaceutical Industry as a strategic partner to their growth. It has recently doubled its printing capacity at its Baddi unit at Himachal Pradesh and setting up of a similar unit In Sikkim is underway. 



 

 


CMT REPORT [Corruption, Money laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 42.81

UK Pound

1

Rs. 83.75

Euro

1

Rs. 66.10

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

YES

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

65

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions